Cormorant Asset Management’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,250,000
Closed -$9.69M 68
2023
Q2
$9.69M Hold
4,250,000
0.54% 41
2023
Q1
$8.33M Buy
+4,250,000
New +$8.8M 0.55% 42

Other funds holding LIAN

Cormorant Asset Management's LIAN Position: Q3 2023 in Review

Cormorant Asset Management sold out of LianBio American Depositary Shares (LIAN) in Q3 2023, closing a stake of 4,250,000 shares — an estimated $9.69M sold.

Cormorant Asset Management first reported a position in LIAN in Q1 2023 and held it in 2 quarters. The position peaked at $9.69M in Q2 2023. 38 funds tracked by Wall St. Rank hold LIAN as of Q3 2023.

  • Cormorant Asset Management reported no remaining LianBio American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Cormorant Asset Management sold 4,250,000 LianBio American Depositary Shares shares in Q3 2023, an estimated $9.69M.
  • Cormorant Asset Management first reported a position in LianBio American Depositary Shares in Q1 2023 and held it in 2 quarters.
  • Cormorant Asset Management's LianBio American Depositary Shares position peaked at $9.69M in Q2 2023.
  • 38 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2023.

Based on Cormorant Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.